Toll-like Receptor 4 Is Upregulated in Parkinson’s Disease Patients and Co-Localizes with pSer129αSyn: A Possible Link with the Pathology
Cells · 11.05.2023 · 12 (10) · 1368
DOI: 10.3390/cells12101368 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, online erschienen am 11.05.2023. Verfasst von Carmela Conte und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, University of Perugia, 06100 Perugia, Italy. Hauptthemen laut MEDLINE: Parkinson Disease. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Amsterdam Neuroscience, Dutch Research Council, Stichting Parkinson Fonds, Alzheimer Association.
Abstract (Originalsprache)
Growing evidence suggests a crucial role of neuroinflammation in the pathophysiology of Parkinson’s disease (PD). Neuroinflammation is linked to the accumulation and aggregation of a-synuclein (αSyn), the primary pathological hallmark of PD. Toll-like receptors 4 (TLR4) can have implications in the development and progression of the pathology. In this study, we analyzed the expression of TLR4 in the substantia nigra (SN) and medial temporal gyrus (GTM) of well-characterized PD patients and age-matched controls. We also assessed the co-localization of TLR4 with pSer129 αSyn. Using qPCR, we observed an upregulation of TLR4 expression in the SN and GTM in PD patients compared to controls, which was accompanied by a reduction in αSyn expression likely due to the depletion of dopaminergic (DA) cells. Additionally, using immunofluorescence and confocal microscopy, we observed TLR4-positive staining and co-localization with pSer129-αSyn in Lewy bodies of DA neurons in the SN, as well as in pyramidal neurons in the GTM of PD donors. Furthermore, we observed a co-localization of TLR4 and Iba-1 in glial cells of both SN and GTM. Our findings provide evidence for the increased expression of TLR4 in the PD brain and suggest that the interaction between TLR4 and pSer129-αSyn could play a role in mediating the neuroinflammatory response in PD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Sciences, University of Perugia, 06100 Perugia, Italy.
- Department of Anatomy and Neurosciences, Amsterdam Neuroscience, Amsterdam UMC, Vrije Universiteit Amsterdam, 1081 HZ Amsterdam, The Netherlands.
ORCID-Profile: Carmela Conte, Wilma D J van de Berg
Förderung
- Amsterdam Neuroscience, Dutch Research Council
- Stichting Parkinson Fonds
- Alzheimer Association
- MJ Fox Foundation
- Parkinson Association
- Health Holland
- Hoffmann-La Roche and Prothena
- Fondo Ricerca di Base di Ateneo, University of Perugia, Perugia, Italy
Zitieren
APA
Conte, C., Ingrassia, A., Breve, J., Bol, J. J., Timmermans-Huisman, E., van Dam, A. M., Beccari, T., & van de Berg, W. D. J. (2023). Toll-like Receptor 4 Is Upregulated in Parkinson’s Disease Patients and Co-Localizes with pSer129αSyn: A Possible Link with the Pathology. Cells, 12(10), 1368. https://doi.org/10.3390/cells12101368
Vancouver
Conte C, Ingrassia A, Breve J, Bol JJ, Timmermans-Huisman E, van Dam AM, et al. Toll-like Receptor 4 Is Upregulated in Parkinson’s Disease Patients and Co-Localizes with pSer129αSyn: A Possible Link with the Pathology. Cells. 2023;12(10):1368. doi:10.3390/cells12101368
BibTeX
@article{Conte2023,
author = {Conte, Carmela and Ingrassia, Angela and Breve, John and Bol, John J and Timmermans-Huisman, Evelien and van Dam, Anne-Marie and Beccari, Tommaso and van de Berg, Wilma D J},
title = {Toll-like Receptor 4 Is Upregulated in Parkinson’s Disease Patients and Co-Localizes with pSer129αSyn: A Possible Link with the Pathology},
journal = {Cells},
year = {2023},
volume = {12},
number = {10},
pages = {1368},
doi = {10.3390/cells12101368}
}
EUVIMED